Related Experiment Videos
Middle ear implantable hearing devices
1College of Integrated Science and Technology, James Madison University, Harrisonburg, VA 22807, USA. spindejh@jmu.edu
American Journal of Audiology
|April 15, 2003
Summary
Middle ear implantable hearing devices (MEIHDs) are now FDA-approved and widely available. Abundant clinical evidence supports their value in rehabilitating sensorineural hearing loss.
Area of Science:
- Otolaryngology
- Biomedical Engineering
- Hearing Device Technology
Background:
- Middle ear implantable hearing devices (MEIHDs) have been under development for over 20 years.
- Two MEIHDs are now FDA-approved for use in the United States, with more in development.
- Over 1500 MEIHDs have been implanted globally, generating substantial clinical data.
Purpose of the Study:
- To provide a comprehensive overview of MEIHDs.
- To offer clinicians background information on MEIHD technologies.
- To aid clinicians in evaluating MEIHDs entering the market.
Main Methods:
- Review of existing clinical evidence on MEIHDs.
- Analysis of technological advancements in MEIHD development.
- Synthesis of data on the efficacy of MEIHDs for hearing loss rehabilitation.
Main Results:
- Extensive clinical evidence supports the efficacy of MEIHDs.
- Multiple MEIHD technologies are available or emerging.
- MEIHDs are a viable option for sensorineural hearing loss rehabilitation.
Conclusions:
- Clinicians should consider MEIHDs as a practical solution for hearing loss.
- Understanding MEIHD technology is crucial for clinical decision-making.
- MEIHDs represent a significant advancement in hearing rehabilitation.